Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹1,811.85
  • Day's High
  • ₹1,874
₹ 1,830.60
  • 52-w low
  • ₹861
  • 52-w high
  • ₹2,194
1,830.60
  • Day's open
    ₹1,866.05
  • Previous close
    ₹1,861.10
  • VWAP
    ₹1,835.70
  • Lower price band
    ₹1,464.50
  • Upper price band
    ₹2,196.70

Today's Market Action

The last traded share price of Gland Pharma Ltd was 1,830.60 down by -1.64% on the NSE. Its last traded stock price on BSE was 1,831.85 down by -1.54%. The total volume of shares on NSE and BSE combined was 226,919 shares. Its total combined turnover was Rs 41.66 crores.

Medium and Long Term Market Action

Gland Pharma Ltd hit a 52-week high of 2,194 on 07-02-2024 and a 52-week low of 861 on 22-05-2023. The stock price of Gland Pharma Ltd is down by 0% over the last one month. It is up by 42.13% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 30150

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

How to Buy Gland Pharma Ltd Share?

What is the Share Price of Gland Pharma Ltd?

What is the Market Cap of Gland Pharma Ltd?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
  • Above Average Growth Rate
    The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only 30.62% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 267 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(27/02/2024)
Stock Valuation
Green line
95
83.33%
83.33% People are bullish about Gland Pharma Ltd
16.67%
16.67 % People are bearish about Gland Pharma Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Gland Pharma Ltd

1,830.60 -30.50 (-1.64%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %